Puccio provided guidance for Q2, stating, "Revenue is expected to be $3.5 billion, plus or minus $100 million. Operating margin at the midpoint is expected to be 47.5%, plus or minus 100 basis points.

The MarketWatch News Department was not involved in the creation of this content. AUDUBON, Pa., Feb. 4, 2026 /PRNewswire/ -- AIROS(R) Medical, Inc., a medical technology manufacturer specializing in ...

AUDUBON, Pa., Feb. 4, 2026 /PRNewswire/ -- AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral vascular disorders, today announced ...

Advanced Micro Devices (AMD) reports Q4 2025 earnings on February 3. Wall Street expects $1.32 EPS on $9.6B revenue. AMD shares gained 112% over the past year. Q3 Data Center revenue hit $4.3B up 22% ...

AUDUBON, Pa., Jan. 14, 2026 /PRNewswire/ -- AIROS Medical, a leading medical technology manufacturer specializing in compression therapy solutions for lymphedema and venous disorders, today announced ...

The U.S. government quietly acquired a device in late 2024 that officials believe may be connected to the debilitating condition known as Havana Syndrome, which more than 1,500 American officials have ...

Don't miss the big stories. Like us on Facebook. AUDUBON, Pa., Jan. 14, 2026 /PRNewswire/ -- AIROS Medical, a leading medical technology manufacturer specializing in compression therapy solutions for ...

Sherri Gordon, CLC is a certified professional life coach, author, and journalist covering health and wellness, social issues, parenting, and mental health. She also has a certificate of completion ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in treating depression, a regulatory milestone that could reshape a mental ...